It has been demonstrated that VEGF inhibition causes a reduction in eNOS expression, which in turn results in a reduction in NO production19, and that this phenomenon is connected to the induction of hypertension, one of the most frequent dose-limiting toxicities of VEGF inhibitors20. This evidence concerns the gene NOS3 and hypertensive disorder.